Senna S Capsule, Liquid Filled
FDA Label NDC 83059-0120

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Shield Pharmaceuticals Corp for the product Senna S (NDC 83059-0120). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredients (in each tablet), purpose, uses, do not use, ask a doctor before use if you have, stop use and ask a doctor if, if pregnant or breast-feeding,, keep out of reach of children., and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Other

Distributed by:
Shield Pharmaceuticals LLCRonkonkoma, NY 11779

Package Label.Principal Display Panel

Senna-S

Docusate Sodium 50 mg and
Sennosides 8.6 mg

Label

Label-front (Label Front)

Label-front (Label Front)

Label-back (Label Back)

Label-back (Label Back)

* Please review the disclaimer below.